
| HOME SCHEDULE PROGRAM AUTHOR INDEX SUBJECT INDEX SIGN UP |
Experimental and Clinical TherapeuticsMonday, October 17, 2005 3:00 PM-5:00 PM Exhibit Hall(PP145) MIBG plus hyperglycemia sensitizes bone marrow CFU-F but not CFU-C to Cs-137 irradiation in Situ. O'Hara, M,*,2, Pollard, M.1, Pocceschi, M.1, Leeper, D.1, 2 Center for Devices and Radiological Health, Rockville, MD, USA1 Radiation Oncology, Philadelphia, PA, USA ABSTRACT- Introduction: Melanoma xenografts are sensitized to hyperthermia, radiation and alkylating agents by hyperglycemia and the respiratory inhibitor meta-iodobenzylguanidine (MIBG). Hyperglycemia and MIBG reduce pHi, pHe, the nucleoside triphosphate:Pi ratio and increase mean pO2 in tumors, but in liver there are only minor changes (Zhou et al., 2000). Axial bone marrow may have hypoxic areas (Allalunis-Turner and Chapman, 1986) and may be chronically acidotic. Thus, bone marrow may be a limiting normal tissue for the techniques that enhance tumor acidification. However, we showed that heating tibias of Balb/c male mice in the presence or absence of hyperglycemia ± MIBG at the same concentrations as used for sensitization of tumors did not sensitize bone marrow to 42°-hyperthermia. Results: To investigate the sensitivity to radiation, bone marrow was irradiated in situ (Cs-137) after administration of 2 g/kg oral glucose ± 22.5 mg/kg MIBG, s.c. After irradiation tibial marrow was flushed out, nucleated cells counted, CFU-C grown in soft agar with colony stimulating factor and CFU-F grown on plastic, and the surviving fraction determined. The radiation survival curve for CFU-C was identical whether bone marrow was irradiated in the presence of excess glucose alone, MIBG alone or excess glucose+MIBG. The Do Key words: CFU-C, CFU-F, hyperglycemia, MIBG |
|
Internet Services provided by Allen Press, Inc. | 810 E. 10th St. | Lawrence, Kansas 66044 USA e-mail assystant-helpdesk@allenpress.com | Web www.allenpress.com 2005 RRS |